422 CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma
Titel:
422 CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma
Auteur:
Haber, M. Murray, J. Gamble, L. Carnegie-Clark, A. Webber, H. Ruhle, M. Carter, D. Oberthur, A. Fischer, M. Ziegler, D. Marshall, G.M. Gurova, K. Burkhart, C. Purmal, A. Gudkov, A.V. Norris, M.D.